The global Vitamin E 50 market exhibited divergent regional trends during Q2 2025, shaped by supply imbalances, feedstock movements, and uneven downstream demand. In the Asia-Pacific region, particularly China, the market softened significantly as high inventory levels and reduced export orders weighed on sentiment. Easing costs of key intermediates such as isophytol and trimethylhydroquinone enabled producers to lower offers, intensifying competitive pricing. Europe mirrored this weakness, with ample supply from Asian exporters and muted demand from nutraceutical and personal care sectors leading to cautious procurement and delayed restocking. In contrast, North America showed relative strength toward the quarter’s close, supported by tighter inventories, firm demand from animal nutrition and pharmaceutical industries, and rising logistics and input costs. Market participants increased purchasing activity in anticipation of seasonal demand, further tightening supply. Overall, the quarter reflected a globally imbalanced market, with Asia-led oversupply contrasting with firmer consumption-driven support in North America.